Krystal Biotech, Inc. (KRYS) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress
August 8, 2022 7:00 AM EDTBiologics License Application for B-VEC filed with the FDA on June 22, 2022FDA accepts IND on KB407 for the treatment of Cystic FibrosisStrong balance sheet, closing the quarter with $438.5 million in cash, cash equivalents and investments
PITTSBURGH, Aug. 08, 2022 (GLOBE NEWSWIRE) --... More
